31.00
Precedente Chiudi:
$30.87
Aprire:
$31.32
Volume 24 ore:
444.10K
Relative Volume:
0.65
Capitalizzazione di mercato:
$1.42B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-67.39
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
+2.07%
1M Prestazione:
+20.81%
6M Prestazione:
-32.61%
1 anno Prestazione:
+3.54%
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OMCL
Omnicell Inc
|
31.00 | 1.42B | 1.08B | -20.76M | 151.63M | -0.46 |
![]()
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-01-03 | Iniziato | Barclays | Underweight |
2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-09-26 | Reiterato | Wells Fargo | Underweight |
2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-09-09 | Iniziato | BofA Securities | Buy |
2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
2021-12-06 | Ripresa | Wells Fargo | Overweight |
2021-06-09 | Iniziato | JP Morgan | Neutral |
2021-05-24 | Iniziato | BTIG Research | Buy |
2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2020-12-08 | Iniziato | Berenberg | Buy |
2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-02-07 | Reiterato | Dougherty & Company | Buy |
2019-11-21 | Reiterato | Dougherty & Company | Buy |
2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
2019-03-07 | Reiterato | Dougherty & Company | Buy |
2018-06-29 | Ripresa | The Benchmark Company | Buy |
2017-09-05 | Reiterato | The Benchmark Company | Buy |
2017-07-28 | Reiterato | Dougherty & Company | Buy |
2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
2017-01-19 | Iniziato | Dougherty & Company | Buy |
2016-12-06 | Reiterato | The Benchmark Company | Buy |
2016-07-07 | Reiterato | FBR Capital | Outperform |
2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
2016-01-07 | Iniziato | The Benchmark Company | Buy |
2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
2015-10-30 | Reiterato | FBR Capital | Outperform |
2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Self-service Pharmacies Market Growth Expected to See Next Level | MedAvail, Omnicell, BD Rowa - openPR.com
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - Yahoo Finance
omnicell announces cfo transition with separation agreement - Investing.com
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Adherence Packaging Market 2025- 2032 Overview: Share, Size, - openPR.com
OMCL: Upcoming Analyst Meetings Could Influence Stock Performanc - GuruFocus
Pharmacy Automation Market Overall Study Report 2025-2032 | - openPR.com
High Volume Dispensing Systems Market Report: Insights, - openPR.com
Omnicell opens innovation lab in Texas - MSN
Central Fill Pharmacy Automation Market Top Companies Study -Omnicell, Inc., McKesson Corporation, ScriptPro LLC - openPR.com
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
Omnicell, Inc. authorizes a Buyback Plan. - marketscreener.com
Omnicell Stock Jumps 5.9% on Strong Profit Guidance and China Tariff CutsNews and Statistics - IndexBox
BofA lifts Omnicell stock price target to $34 from $30 - Investing.com Australia
BofA lifts Omnicell stock price target to $34 from $30 By Investing.com - Investing.com Nigeria
Why Omnicell (OMCL) Stock Is Trading Up Today - Yahoo Finance
Omnicell upgraded at Wells Fargo on positive risk-reward setup - MSN
Omnicell Inc (OMCL) Shares Down 3.27% on May 21 - GuruFocus
Omnicell (OMCL) Adjusts Q2 Revenue and EBITDA Guidance | OMCL St - GuruFocus
Omnicell Updates Q2, 2025 Earnings Guidance, Approves New $75 Million Share Buyback Plan - marketscreener.com
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Pla - GuruFocus
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Plan | OMCL Stock News - GuruFocus
Omnicell (OMCL) Updates FY25 Outlook Amid Tariff Reductions | OM - GuruFocus
Omnicell Updates 2025 Guidance and Stock Buyback Plan - TipRanks
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - BioSpace
Omnicell Expects Improved Profitability, Updates Second Quarter - GuruFocus
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program | OMCL Stock News - GuruFocus
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omnicell Inc Azioni (OMCL) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):